These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9127156)

  • 21. The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
    Huerta-Enochian G; Katz V; Erfurth S
    Am J Obstet Gynecol; 2001 Jun; 184(7):1549-53; discussion 1553-5. PubMed ID: 11408879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated maternal mid-trimester chorionic gonadotropin > or =4 MoM is associated with fetal cerebral blood flow redistribution.
    Hershkovitz R; Erez O; Sheiner E; Landau D; Mankuta D; Mazor M
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):22-7. PubMed ID: 12580835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Labor induction versus expectant management at early term in pregnancies with second trimester elevated human chorionic gonadotropin or alpha fetoprotein.
    Yefet E; Kuzmin O; Schwartz N; Basson F; Nachum Z
    J Obstet Gynaecol Res; 2018 Jun; 44(6):1049-1056. PubMed ID: 29516643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quad screen as a predictor of adverse pregnancy outcome.
    Dugoff L; Hobbins JC; Malone FD; Vidaver J; Sullivan L; Canick JA; Lambert-Messerlian GM; Porter TF; Luthy DA; Comstock CH; Saade G; Eddleman K; Merkatz IR; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fetal growth retardation and second trimester maternal serum human chorionic gonadotrophin levels.
    Luckas MJ; Sandland R; Hawe J; Neilson JP; McFadyen IR; Meekins JW
    Placenta; 1998; 19(2-3):143-7. PubMed ID: 9548180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease.
    Dinglas C; Afsar N; Cochrane E; Davis J; Kim S; Akerman M; Wells M; Chavez M; Herrera K; Heo H; Vintzileos A
    Am J Obstet Gynecol; 2020 May; 222(5):499.e1-499.e6. PubMed ID: 31794723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of unexplained high serum alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in the second trimester to determine poor obstetric outcomes.
    Öztürk H; Erkaya S; Altınbaş S; Karadağ B; Vanlı Tonyalı N; Özkan D
    Turk J Obstet Gynecol; 2014 Sep; 11(3):142-147. PubMed ID: 28913007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
    Spencer K
    Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive Value of Second-Trimester Biomarkers and Maternal Features for Adverse Pregnancy Outcomes.
    Yefet E; Kuzmin O; Schwartz N; Basson F; Nachum Z
    Fetal Diagn Ther; 2017; 42(4):285-293. PubMed ID: 28395283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
    Williams MA; Hickok DE; Zingheim RW; Luthy DA; Kimelman J; Nyberg DA; Mahony BS
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1032-7. PubMed ID: 1384333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between unexplained elevated serum markers in triple test, uterine artery Doppler measurements and adverse pregnancy outcome.
    Karsidag AY; Buyukbayrak EE; Kars B; Suyugul U; Unal O; Turan MC
    J Pak Med Assoc; 2010 Mar; 60(3):181-6. PubMed ID: 20225773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion.
    Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
    Am J Perinatol; 1996 Oct; 13(7):437-41. PubMed ID: 8960614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of adverse perinatal outcome by maternal serum screening for Down syndrome in an Asian population.
    Hsieh TT; Hung TH; Hsu JJ; Shau WY; Su CW; Hsieh FJ
    Obstet Gynecol; 1997 Jun; 89(6):937-40. PubMed ID: 9170469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosomal abnormalities and adverse pregnancy outcome with maternal serum second trimester triple screening test for fetal Down syndrome in 4,860 Chinese women.
    Xia YP; Zhu MW; Li XT; Zhou HP; Wang J; Lv JX; Zhong N
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 38(1):49-52. PubMed ID: 16415966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down's syndrome.
    Kim SY; Kim SK; Lee JS; Kim IK; Lee K
    Yonsei Med J; 2000 Apr; 41(2):226-9. PubMed ID: 10817024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.
    Konchak PS; Bernstein IM; Capeless EL
    Am J Obstet Gynecol; 1995 Oct; 173(4):1115-9. PubMed ID: 7485303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
    Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R
    Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.